ING Groep NV bought a new position in Everus (NYSE:ECG - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 36,250 shares of the company's stock, valued at approximately $2,383,000. ING Groep NV owned 0.07% of Everus at the end of the most recent reporting period.
A number of other hedge funds also recently added to or reduced their stakes in ECG. Forza Wealth Management LLC bought a new stake in shares of Everus during the 4th quarter worth about $336,000. Mendota Financial Group LLC acquired a new stake in Everus during the 4th quarter worth about $36,000. SeaCrest Wealth Management LLC purchased a new position in shares of Everus in the fourth quarter worth approximately $292,000. Hennessy Advisors Inc. acquired a new stake in shares of Everus during the fourth quarter valued at approximately $31,611,000. Finally, Brady Martz Wealth Solutions LLC purchased a new stake in shares of Everus in the 4th quarter valued at approximately $472,000.
Insiders Place Their Bets
In related news, Director Rocca Michael Della bought 1,050 shares of the firm's stock in a transaction on Tuesday, February 18th. The stock was purchased at an average price of $47.56 per share, with a total value of $49,938.00. Following the completion of the transaction, the director now directly owns 2,027 shares of the company's stock, valued at $96,404.12. This trade represents a 107.47 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Everus Trading Up 6.8 %
Shares of NYSE ECG traded up $2.88 during mid-day trading on Wednesday, reaching $45.18. The company had a trading volume of 1,253,059 shares, compared to its average volume of 756,589. The company has a current ratio of 1.58, a quick ratio of 1.50 and a debt-to-equity ratio of 0.47. Everus has a twelve month low of $37.84 and a twelve month high of $77.93. The stock has a 50 day simple moving average of $64.64.
Everus (NYSE:ECG - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The company reported $0.67 earnings per share for the quarter, missing analysts' consensus estimates of $0.73 by ($0.06). As a group, sell-side analysts anticipate that Everus will post 2.49 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
ECG has been the topic of several research analyst reports. Stifel Nicolaus lowered their price objective on shares of Everus from $85.00 to $67.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. DA Davidson assumed coverage on Everus in a research report on Monday, November 4th. They set a "neutral" rating and a $55.00 price target on the stock. Oppenheimer increased their price objective on Everus from $70.00 to $80.00 and gave the stock an "outperform" rating in a research note on Tuesday, January 7th. Finally, Wolfe Research initiated coverage on Everus in a report on Tuesday, December 3rd. They issued a "peer perform" rating on the stock.
Check Out Our Latest Stock Analysis on ECG
Everus Profile
(
Free Report)
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.
Recommended Stories

Before you consider Everus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Everus wasn't on the list.
While Everus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.